Boston Scientific is a leader in the field of SCS — dedicated to helping patients manage pain.
It all started with the launch of the Precision™ Spinal Cord Stimulator (SCS) System. As the world's first system with a dedicated power source for each contact, a rechargeable battery, and innovative programming software, we advanced the world of SCS. While Precision was ahead of its time, we knew we were just getting started.
Recent clinical data show sustained and highly significant reduction in overall pain and low back pain 24 months post-implant with the Boston Scientific Precision Spectra™ SCS System.
Additionally LUMINA data demonstrates 70% greater low back pain relief with the Precision Spectra System than with the previous generation Precision Plus™ SCS System.
Frey et al., Long-Term Reduction in Back Pain and Disability with Anatomically-Guided Neural Targeting: Final Results of the Multicenter LUMINA Study, Presented at the North American Neuromodulation Society 19th Annual Meeting, Las Vegas, NV 2015.
Note: Clinical study results may not necessarily be indicative of clinical performance. Results in other studies may vary.
Our vision was to define the future of SCS by providing more pain relief to a broader spectrum of patients. That was the guiding principle in the development of our next-generation system.
The world's first SCS system with 32 contacts and 32 dedicated power sources, the Precision Spectra™ SCS System is designed to provide unprecedented pain coverage, an entirely new level of flexibility, and advanced control for delivering stimulation in ways never before possible.
When you control movement of the CPS along the spinal cord in increments as small as a human hair, you can target the area of pain for unparalleled accuracy. Only Boston Scientific offers this level of control. Single-source systems do not.
Designed for a new level of flexibility. Four ports and an unrivaled percutaneous lead portfolio for unmatched flexibility, now and in the future.
The Precision Spectra System gives you an entirely new level of flexibility. Unprecedented lead configurations provide more choices to manage your patients' unique pain patterns.
Guided by our next-generation 3D programming algorithm, Precision Spectra SCS is engineered to provide advanced control for delivering stimulation in ways never before possible. The Illumina 3D Algorithm generates advanced anode/cathode configurations to best target the selected central points of stimulation, allowing you to create a customized stimulation field.
Illumina 3D™ Programming Algorithm
Leads exist in a complex 3-dimensional environment. The Illumina 3D Algorithm is the first and only programming software that takes this into account.
Visually intuitive and elegantly simple user interface.
The only programming software to account for lead offset.
SCS was originally based on pacemaker technology. Other SCS systems are still built on this technology today. Boston Scientific SCS Systems were based on more advanced technology — the cochlear implant. Compared to pacemakers that had one power source for stimulation, cochlear implant technology had dedicated power sources for each contact to allow independent control of stimulation, which is substantially more precise than a pacemaker.
If you want more information about Boston Scientific SCS, simply fill out the form and one of our knowledgeable Customer Care Specialists will contact you within 48 hours. You can also reach our reps by calling 866.360.4747.
*All fields are required
If you have any questions at all, you can always reach one of our Customer Care Specialists using the phone number below.
Download the Illumina 3D Family Brochure to learn about the leading-edge technology of Illumina 3D programming and what that means for you and your patients.
(Pdf 1,066 Kb)